# Black Diamond Therapeutics, Inc.: Form SC 13D/A, filed May 9, 2024

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: SC 13D/A
- Filed: 2024-05-09
- Accepted by EDGAR: May 9, 2024, 20:48 ET
- Period: not reported
- Accession: 0001104659-24-059533
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465924059533/tm2414095d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465924059533/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465924059533/tm2414095d1_sc13da.htm

Filed May 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-059533. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.